Literature DB >> 10334162

Clinical uses of low-molecular-weight heparins.

D Aguilar1, S Z Goldhaber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10334162     DOI： 10.1378/chest.115.5.1418

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

1.  Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?

Authors:  Wesley D Kufel; Robert W Seabury; William Darko; Luke A Probst; Christopher D Miller
Journal:  Hosp Pharm       Date:  2017-03

Review 2.  Fondaparinux sodium.

Authors:  Susan J Keam; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study.

Authors:  Michael Joannidis; Jordan Kountchev; Markus Rauchenzauner; Nicola Schusterschitz; Hanno Ulmer; Andreas Mayr; Romuald Bellmann
Journal:  Intensive Care Med       Date:  2007-06-12       Impact factor: 17.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.